Evidence map›Paper›PMID 26492464›Full record

ReviewSmall GTPases2015

Switching Rho GTPase activation into effective antibacterial defenses requires the caspase-1/IL-1beta signaling axis.

Laurent Boyer, Emmanuel Lemichez

Open access · bronzeAbstract readReview
In one paragraph

Review in Small GTPases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Laurent Boyera INSERM; U1065; Center Méditerranéen de Médecine Moléculaire; C3M; Toxines Microbiennes dans la relation hôte pathogènes; Equipe Labellisée Ligue Contre le Cancer ; Nice , France.
Emmanuel Lemicheza INSERM; U1065; Center Méditerranéen de Médecine Moléculaire; C3M; Toxines Microbiennes dans la relation hôte pathogènes; Equipe Labellisée Ligue Contre le Cancer ; Nice , France.
Centre Méditerranéen de Médecine Moléculaire · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The monitoring of the activation state of Rho GTPases has emerged as a potent innate immune mechanism for detecting pathogens. In the March issue of PLOS Pathogens, we show that the activation of Rho GTPases by the CNF1 toxin during E. coli-triggered bacteremia leads to a GR1(+)cell-mediated efficient bacterial clearing and improves host survival. Host alarm requires the Caspase-1/IL-1beta signaling axis. Furthermore, we discover that pathogenic bacteria have the capacity to block immune responses via the expression of the α-hemolysin pore-forming toxin. In this commentary, we will comment on these findings and highlight the questions raised by this example of attack-defense mechanisms used alternatively by the pathogen and the host during blood infection.

Indexed as

AnimalsBacterial ToxinsCaspase 1Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHemolysin ProteinsHumansInterleukin-1betarho-Associated KinasesSignal TransductionBacterial ToxinsCaspase 1cytotoxic necrotizing factor type 1Escherichia coli ProteinsHemolysin ProteinsHlya protein, E coliIL1B protein, humanInterleukin-1betarho-Associated Kinasesantibacterial defensesbacterial effectorsbacterial toxinscaspase-1effector-triggered immunityIl-1betainnate immunity

Identifiers

PMID26492464
PMCPMC4905264
OpenAlexW1805305072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.